Cotiviti Holdings, Inc. (COTV) to Offer 10M Shares for Holders
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Cotiviti Holdings, Inc. (NYSE: COTV) announced that certain stockholders of the Company intend to offer 10,000,000 shares of the Company’s common stock, par value $0.001 per share, in an underwritten public offering. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,500,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The offering consists entirely of secondary shares to be sold by the Selling Stockholders. The Selling Stockholders will receive all of the proceeds from the offering.
Goldman, Sachs & Co. and J.P. Morgan are serving as joint lead book-running managers and as representatives of the underwriters for the proposed offering. Barclays, Citigroup, Credit Suisse, Morgan Stanley and SunTrust Robinson Humphrey are acting as joint book-running managers for the proposed offering. Baird, William Blair and Leerink Partners are acting as co-managers for the proposed offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keane Group (FRAC) IPO Opens Up 16%
- UPDATE: SunTrust Robinson Humphrey Downgrades Simon Property Group (SPG) to Hold
- Keane Group (FRAC) IPO Prices at $19/Share
Create E-mail Alert Related CategoriesEquity Offerings
Related EntitiesCredit Suisse, William Blair, JPMorgan, Citi, Morgan Stanley, Robert W Baird, SunTrust Robinson Humphrey, Barclays, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!